Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing. | UCSF Helen Diller Family Comprehensive Cancer Center

Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing.

Author List

Hertz DL, Venook AP

Publication

JCO precision oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/679821253

Publication Year

2025

PubMed ID

40638877